Medical News

Daily news and information for physicians in a range of specialties and practice settings.

Latest Medical News

GLP-1 Receptor Agonists and Thyroid Cancer: Differentiating Cancer Type
GLP-1 Receptor Agonists and Thyroid Cancer: Differentiating Cancer Type
GLP-1 receptor antagonists have been associated with thyroid cancer in rodents, and in fact carry a boxed warning about the potential for cancer in humans. This leads many clinicians to ask if they should be concerned about using these drugs in patients who have or develop specific types of thyroid cancer
Dementia and Comorbid Diabetes and Depression
Dementia is linked to comorbid diabetes and psychiatric conditions like depression, according to research from University College London.
CDC Alarmed by US Tapeworm Brain Infections
Seizures and other neurological problems traced to pork tapeworms are a new health threat for the US, the CDC reports.
The High Cost of Arthritis Treatment
A recent study examined the cost of biologic and non-biologic DMARDs under Medicare Part D and stand-alone coverage plans.
Salmonella Outbreak in 9 States Due to Sushi Confirmed by CDC
A salmonella outbreak traced back to sushi made with raw tuna has infected a total of 53 individuals so far.
International Federation of Psoriasis Associations Publishes Issue Brief to Raise Awareness of Psoriatic Arthritis
Early diagnosis and treatment is the key to preventing long-term joint damage in patients with psoriatic arthritis.
The 9 States with the Highest Drunk Driving Rates
Nationally, 1.9% of adults admit to driving while drunk at least once in the past 30 days. These states have rates even higher than the national average.

Product News

FDA Okays Hep-C Investigational Combo for Post-Transplant Patients
FDA Okays Hep-C Investigational Combo for Post-Transplant Patients
The FDA says the investigational drug combination of daclatasvir (Daklinza/ Bristol-Myers Squibb) and sofosbuvir (Sovaldi/Gilead ) may now be given to patients who have hepatitis C infections with either advanced cirrhosis or infections that have come back after patients received a liver transplant.
Longer Lasting Version of Schizophrenia Drug Approved
The US Food and Drug Administration today approved 3-month paliperidone palmitate (Invega Trinza/Janssen) a longer-lasting version of Janssen’s paliperidone palmitate product marketed as Invega Sustenna, a treatment that works for only 1 month per injection.
New Transplant Drug Reduces Rejection Risk
A 7-year followup study of a drug approved in 2011 shows it has better results than cyclosporine in kidney patients. But it comes with a warning.
FDA Approves Kidney Failure Device
FDA approves device to help kidney failure patients with dialysis-related-amyloidosis. Known as the Lixelle Beta-2 microglobulin Apheresis Column, the device is already in use in Japan, where it is manufactured.
First Biosimilar Approved
The US Food and Drug Administration (FDA) approved its first biosimilar product filgrastim-sndz (Zarxio/Sandoz), a cancer drug that is similar to Amgen’s filgrastim (Neupogen).
FDA Warning: Testosterone Can Kill
Manufacturers of prescription testosterone products must change their drug labels to include a warning about increased risk of heart attacks and strokes. The labeling change, announced today by the US Food and Drug Administration (FDA) addresses the use of testosterone by men whose decreased level of the hormone is due to aging.

Most Popular

$vacMongoViewPlus$ $vAR$